Value-based care | pharmaphorum

Skip to main content

Tuesday 23 April 2024

twitter linkedin facebook rss

User account menu

Sign up

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

close

Channels

Content type

Categories

Categories

Sort by

Order

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

Sign up

twitter linkedin facebook rss

Sign in

Value-based care

Patients

patient and HCP

How can the value of patient engagement be quantified and me...

In a 2023 framework, the World Health Organization (WHO) defined meaningful engagement as the respectful, dignified, and equitable inclusion of individuals with lived experience, following

R&D

Reuters Pharma USA – Lung-I Cheng

Reuters Pharma USA – Lung-I Cheng

Cell and gene therapies continue to be hot topics in the pharma world this year, and some companies are responding to the new treatment modalities with new business units.

Partner Content

Europe health technology and digital care

Partner Content

Healthcare tech: the driving force behind value-based care?

In 2020, healthcare technology investment went into overdrive.

Views & Analysis

Pharma must put patients at the centre

Pharma must put patients at the centre of the shift to value...

The pharma industry has been talking about the healthcare sector's move to value-based care for some time.

Editor's Picks

Ipsen signs $1.8bn RNA drug alliance with Skyhawk

Metsera lands with $290m to take on obesity giants

Regeneron launches $500m venture capital arm

Telehealth firm Cerebral faces $7m FTC fine over privacy

GSK trails after Pfizer in 5-in-1 meningococcal vaccine race

News

Novartis chief executive Vas Narasimhan

Novartis names ex-BMS CEO Caforio as chair amid strong Q1

Novartis has posted a healthy rise in sales and profits in the first full quarter since it separated from Sandoz and proposed former Bristol Myers Squibb’s chief executive

Digital

pharmaphorum podcast episode 121

Fixing clinical trial data management

It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

rss facebook linkedin twitter

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – a Healthware Group company